Follow your device's specific IFU carefully
Signs you're ready to move to the next dose: GI symptoms (nausea, vomiting, diarrhea) have resolved or are minimal for at least 7 consecutive days Appetite suppression remains noticeable but you sense a plateau effect developing at the current dose You have completed at least 4 full weeks at the current dose level You have no significant intercurrent illness that might confuse attribution of new symptoms Signs to wait: Ongoing nausea or vomiting, even if mild, at the end of the current dose phase A recent GI illness (unrelated to the medication) that makes it hard to attribute current symptoms A major life stressor or schedule disruption that might amplify side effects Fewer than 4 weeks at the current dose, regardless of how you feel When in doubt, an additional week at the current dose costs very little
The blood flow to bones is vital for skeletal health, and GLP-1RAs may improve it, while the precise processes are not entirely known
PS exposure is not affected by body mass index (BMI), age, gender, or ABO/Rh blood group [474]
Because of these divisions, a drugs benefit channel can determine patient cost and access
